Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/8782b7f8-1939-4e7a-84eb-4daadcf935ca/

IOLCP

IOL Chemicals and Pharmaceuticals Limited
Chart
₹131.68
Latest Week 2026-06-05
HealthcareDrug Manufacturers - Specialty & GenericLARGE
Snapshot 2026-06-07 · 0.0w · Fresh
0.86
OS Score
65.0%
Value
63.0%
Quality
89.0%
Momentum
7/9
F-Score
0.640
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
3 of 23 passing
★
OS Composite
OS 0.860
↗
Trending Value
✗
◆
Quality × Value
QV 0.640
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
F7
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
65.0%ile
P/E
28.1×
P/S
1.7×
P/B
2.1×
E/P
0.0356
FCF Yield
0.011
EBITDA/EV
0.071
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
34.00000000
/100 — 1=cheapest
VC2 (Trending Value)
37.00000000
/100
VC3 (Buyback)
38.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
63.0%ile
ROE
0.077
ROA
0.053
Net Margin
0.059
Op Margin
0.081
GPA
0.322
Current
1.78
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.115
Earn Growth
0.362
Stability
0.353
lower=better
Accruals
-0.030
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
89.0%ile
6M Return
58.1%
12M Return
50.4%
12-1 Mom
10.7%
Risk-Adj
0.24
Vol 252d
45.0%
Vol 60d
90.3%
↑ Expanding
Max DD 12M
-42.4%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (90%) is expanding vs long-term (45%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.86
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 160 peers
Sector Value %ile
84.5%
Sector Quality %ile
42.9%
P/E z-score
-0.20
P/B z-score
-0.70
Sector Avg OS
43.5%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
NATCOPHARM NATCO Pharma Limited 98.0% 88.0% 87.0% 81.0%
LINCOLN Lincoln Pharmaceuticals Limited 97.0% 88.0% 80.0% 81.0%
UNIVPHOTO Universus Photo Imagings Limited 97.0% 86.0% 74.0% 94.0%
VENUSREM Venus Remedies Limited 96.0% 68.0% 94.0% 99.0%
STAR Strides Pharma Science Limited 96.0% 73.0% 91.0% 91.0%
HALEOSLABS Haleos Labs Limited 95.0% 82.0% 77.0% 81.0%
AUROPHARMA Aurobindo Pharma Limited 94.0% 71.0% 84.0% 87.0%
SAGILITY Sagility Limited 93.0% 76.0% 81.0% 76.0%
Factor Interactions
Hot but Volatile
Strong momentum (89th) but high volatility (45%). Momentum could reverse sharply.
Volatility Expanding
60-day vol (90%) significantly exceeds 252-day (45%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
44.2% avg (7 factors)
Quality
D
44.3% avg (7 factors)
Momentum
B
67.0% avg (4 factors)
Risk
D
41.7% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.860—1—
Value %ile0.650—0—
Quality %ile0.630—0—
Momentum %ile0.890—1—
F-Score7.000—1—
Confidence0.939—1—
Volatility0.450—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
28.08
Earnings Yield (E/P)
0.0356
Price / Sales
1.67
Price / Book
2.15
Price / Cash Flow
18.03
FCF Yield
1.1%
EBITDA / EV
7.1%
Sales Yield (1/P·S)
0.5893
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
7.7%
Return on Assets
5.3%
Net Margin
5.9%
Operating Margin
8.1%
Gross Profit / Assets
Novy-Marx GPA
32.2%
Current Ratio
1.78
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.030
MomentumPrice trend strength over different horizons
6M Return
58.1%
12M Return
50.4%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
10.7%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.24
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
11.5%
Earnings Growth (YoY)
36.2%
Earnings Stability (CV)
Lower = more stable
0.353
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
7
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
34
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
37
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
38
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity